Skip to main content

Our failure to advance new treatments for glioma to market.

Publication ,  Journal Article
Sampson, JH; Kaminski, TJ; Schulman, KA
Published in: J Neurosurg
August 2011

Duke Scholars

Published In

J Neurosurg

DOI

EISSN

1933-0693

Publication Date

August 2011

Volume

115

Issue

2

Start / End Page

245 / 247

Location

United States

Related Subject Headings

  • Neurology & Neurosurgery
  • Male
  • Humans
  • Glioblastoma
  • Female
  • Cancer Vaccines
  • Brain Neoplasms
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sampson, J. H., Kaminski, T. J., & Schulman, K. A. (2011). Our failure to advance new treatments for glioma to market. J Neurosurg, 115(2), 245–247. https://doi.org/10.3171/2010.11.JNS101436
Sampson, John H., Thomas J. Kaminski, and Kevin A. Schulman. “Our failure to advance new treatments for glioma to market.J Neurosurg 115, no. 2 (August 2011): 245–47. https://doi.org/10.3171/2010.11.JNS101436.
Sampson JH, Kaminski TJ, Schulman KA. Our failure to advance new treatments for glioma to market. J Neurosurg. 2011 Aug;115(2):245–7.
Sampson, John H., et al. “Our failure to advance new treatments for glioma to market.J Neurosurg, vol. 115, no. 2, Aug. 2011, pp. 245–47. Pubmed, doi:10.3171/2010.11.JNS101436.
Sampson JH, Kaminski TJ, Schulman KA. Our failure to advance new treatments for glioma to market. J Neurosurg. 2011 Aug;115(2):245–247.

Published In

J Neurosurg

DOI

EISSN

1933-0693

Publication Date

August 2011

Volume

115

Issue

2

Start / End Page

245 / 247

Location

United States

Related Subject Headings

  • Neurology & Neurosurgery
  • Male
  • Humans
  • Glioblastoma
  • Female
  • Cancer Vaccines
  • Brain Neoplasms
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1109 Neurosciences